फलो गर्नुहोस्
Englishनेपाली
← पछाडि

Insulin glargine

Injection100IU२२ ब्रान्ड उत्पादन
Insulin glargine NepalDoc औषधि सूचीमा रहेको औषधि हो। NepalDoc औषधि सूचीमा यसका २२ वटा ब्रान्ड उत्पादन छन्।
सामान्य नाम (Generic name)insulin glargine
रूप र शक्ति (Form & strength)Catalog forms: Cartridge, Injection, Pen, Vial · Catalog strengths: 100IU
स्रोतNepalDoc medicine catalog
स्रोतU.S. FDA-approved label via DailyMed (label effective 16 Jun 2026) · NepalDoc medicine catalog · अमेरिकी लेबलिङ नेपालको DDA-स्वीकृत लेबलिङ र स्थानीय प्रिस्क्राइबिङ अभ्यासभन्दा फरक हुन सक्छ।

What it's for

BASAGLAR ® is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

From the U.S. FDA-approved label for Insulin glargine. Full label: DailyMed.

BASAGLAR ® is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

From the U.S. FDA-approved label for Insulin glargine. Full label: DailyMed.

Individualize dosage based on metabolic needs, blood glucose monitoring, glycemic control, type of diabetes, prior insulin use. Administer subcutaneously once daily at any time of day, but at the same time every day. Rotate injection sites into the abdominal area, thigh, or deltoid to reduce the risk of lipodystrophy and localized cutaneous amyloidosis.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

BASAGLAR is contraindicated: During episodes of hypoglycemia. In patients with hypersensitivity to insulin glargine or any of the excipients in BASAGLAR. During episodes of hypoglycemia. Hypersensitivity to BASAGLAR or any of its excipients.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Never share a BASAGLAR prefilled pen between patients, even if the needle is changed. Hyperglycemia or hypoglycemia with changes in insulin regimen: Make changes to a patient's insulin regimen (e.g., insulin strength, manufacturer, type, injection site or method of administration) under close medical supervision with increased frequency of blood glucose monitoring. Hypoglycemia: May be life-threatening.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following adverse reactions are discussed elsewhere: Hypoglycemia. Hypoglycemia Due to Medication Errors. Hypersensitivity Reactions. Hypokalemia. Adverse reactions commonly (≥5%) associated with insulin glargine products are: Hypoglycemia, allergic reactions, injection site reaction, lipodystrophy, pruritus, rash, edema, and weight gain.

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

22 products from 8 makers in the NepalDoc medicine catalog use this generic:

BrandCompositionMakerPack
Glaritus InjectionInsulin GlargineWockhardt Ltd.
Lantus 100IU CartridgeInsulin Glargine (100IU)Sanofi India Ltd.
Lantus InjectionInsulin GlargineAventis Pharma Limited.
Lantus Solostar 100IU PenInsulin Glargine (100IU)Sanofi India Ltd.
Lantus Starter VialInsulin GlargineAventis Pharma Limited.
Lantus U 100 VialInsulin GlargineAventis Pharma Limited.
Basaglar 100 Units/ml CartridgeInsulin Glargine (3.64IU/ml)Cipla Ltdcartridge of 3 ml Solution for Injection
Basaglar 100IU/ml KwikpenInsulin Glargine (100IU/ml)Cipla Ltdpre-filled pen of 3 ml Solution for Injection
Basalog 100IU/ml InjectionInsulin Glargine (100IU/ml)Bioconvial of 10 ml Injection
Basalog 100IU/ml Refill CartridgeInsulin Glargine (100IU/ml)Bioconcartridge of 3 ml Solution for Injection
Basalog One 100IU/ml InjectionInsulin Glargine (100IU)Bioconpre-filled pen of 3 ml Injection
Basugine 100IU/ml InjectionInsulin Glargine (100IU)Lupin Ltdcartridge of 3 ml Injection
Glaritus 100IU/ml DispopenInsulin Glargine (100IU)Wockhardt Ltdpacket of 3 ml Injection
Glaritus 100IU/ml InjectionInsulin Glargine (100IU)Wockhardt Ltdcartridge of 3 ml Injection
Glaritus 100IU/ml Injection 3mlInsulin Glargine (100IU)Wockhardt Ltdpacket of 3 cartriges
Glaritus 40IU/ml InjectionInsulin Glargine (40IU)Wockhardt Ltdvial of 10 ml Injection
Glaritus Dispopen 2Insulin Glargine (100IU/ml)Wockhardt Ltdpre-filled pen of 3 ml Injection
Glarzen 100IU/ml Dispopen 2Insulin Glargine (100IU/ml)Wockhardt Ltdpre-filled pen of 3 ml Injection
Lantus 100IU/ml Solution for InjectionInsulin Glargine (100IU)Sanofi India Ltdcartridge of 3 ml Solution for Injection
Lantus Solostar 100IU/ml Solution for InjectionInsulin Glargine (100IU/ml)Sanofi India Ltdpre-filled pen of 3 ml Solution for Injection
Toujeo 300 U/mL SolostarInsulin Glargine (300u/ml)Sanofi India Ltdpre-filled pen of 1 Solution for Injection
Toujeo 300U/ml Cartridge (1.5ml Each)Insulin Glargine (300u/ml)Sanofi India Ltdpacket of 3 cartriges

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

16.2 Storage and Handling Dispense in the original sealed carton with the enclosed Instructions for Use. Protect BASAGLAR from heat and light. Do not freeze BASAGLAR. In-use BASAGLAR prefilled pens must be used within 28 days or be discarded, even if they still contain BASAGLAR.

Storage information from the U.S. FDA-approved label.

Browse A–Z5ABCDEFGHIJKLMNOPQRSTUVWXYZ

अन्तरक्रिया (Interactions)

अन्य औषधि, खाना र जडीबुटी उत्पादनले Insulin glargine को काम बदल्न सक्छन्। Insulin glargine को FDA लेबलले यसको अन्तरक्रिया खण्डमा १० अन्य औषधिको नाम लिएको छ।

Insulin glargine का अन्तरक्रिया हेर्नुहोस् →

एपमा औषधि खोज्नुहोस् फार्मेसी खोज्नुहोस्
+ सुरक्षा जानकारी

यो पृष्ठ सामान्य जानकारीका लागि मात्र हो, चिकित्सकीय सल्लाह होइन। औषधि प्रयोग गर्नुअघि डाक्टर वा फार्मासिस्टसँग सल्लाह लिनुहोस्। विवरण माथि उल्लेखित स्रोतहरूबाट आएको हो र परिवर्तन हुन सक्छ। सूचीमा हुनुले कुनै फार्मेसीमा औषधि उपलब्ध छ भन्ने ग्यारेन्टी दिँदैन।

यो औषधि सेयर गर्नुहोस्
NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.